Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New data from Lund University illuminate research in breast cancer
May 28th, 2009
According to a study from Malmo, Sweden, "It is plausible that polymorph isms in the estrogen receptor alpha and beta genes (ESR1 and ESR2) may modulate the association between enterolactone and breast cancer. Seven polymorph isms in ESR1 (rs827422, rs1709184, rs2347867, rs3020328, rs72207, rs2982896, and rs2234693) and 5 polymorphisms in ESR2 (rs915057, rs1269056, rs1256033, rs3020450, and rs3020443) were selected." "The risk of breast cancer for these polymorphisms was estimated among 542 cases and 1076 matched controls from the population-based Malmo Diet and Cancer cohort. The joint effect of these polymorphisms and enterolactone was estimated among those...
Source: Women's Health Weekly (2009-05-28)
|
